Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retention rate of IL-1 inhibitors in Schnitzler's syndrome.
Crisafulli F, Vitale A, Airò P, Grigis M, Gaggiano C, Dagna L, Cavalli G, Cimaz R, Viapiana O, Iannone F, Lopalco G, Bortolotti R, Abdel Jaber M, Montecucco C, Monti S, Balduzzi S, Emmi G, Mattioli I, Franceschini F, Cantarini L, Frassi M. Crisafulli F, et al. Among authors: balduzzi s. Clin Exp Rheumatol. 2022 Nov;40(11):2011-2017. doi: 10.55563/clinexprheumatol/14hu2k. Epub 2022 Jan 12. Clin Exp Rheumatol. 2022. PMID: 35084307 Free article.
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.
Sebastiani M, Venerito V, Bugatti S, Bazzani C, Biggioggero M, Petricca L, Foti R, Bortoluzzi A, Balduzzi S, Visalli E, Frediani B, Manfredi A, Gremese E, Favalli E, Iannone F, Ferraccioli G, Lapadula G; Contributors. Sebastiani M, et al. Among authors: balduzzi s. Clin Rheumatol. 2021 Oct;40(10):4039-4047. doi: 10.1007/s10067-021-05734-3. Epub 2021 Apr 21. Clin Rheumatol. 2021. PMID: 33881676
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection.
Batticciotto A, Marotto D, Giorgi V, Balzarini P, Favalli EG, Balduzzi S, Fredi M, Bazzani C, Sartorelli S, Ravagnani V, Tamanini S, Castelnovo L, Lurati AM, Farah S, Bongiovanni S, Caporali R, Dagna L, Faggioli P, Franceschini F, Montecucco CM, Salaffi F, Galli M, Cappelli A, Sarzi-Puttini P. Batticciotto A, et al. Among authors: balduzzi s. Clin Exp Rheumatol. 2021 May-Jun;39(3):695. doi: 10.55563/clinexprheumatol/6z3ong. Epub 2021 Feb 26. Clin Exp Rheumatol. 2021. PMID: 33635224 Free article. No abstract available.
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.
Ruscitti P, Di Cola I, Berardicurti O, Conforti A, Iacono D, Pantano I, Rozza G, Rossi S, De Stefano L, Balduzzi S, Vitale A, Caso F, Costa L, Prete M, Navarini L, Atzeni F, Guggino G, Perosa F, Cantarini L, Frediani B, Montecucco C, Ciccia F, Giacomelli R, Cipriani P. Ruscitti P, et al. Among authors: balduzzi s. Clin Rheumatol. 2022 Mar;41(3):641-647. doi: 10.1007/s10067-021-05929-8. Epub 2021 Oct 11. Clin Rheumatol. 2022. PMID: 34636022
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.
Ruscitti P, Di Cola I, Berardicurti O, Conforti A, Iacono D, Pantano I, Rozza G, Rossi S, De Stefano L, Balduzzi S, Vitale A, Caso F, Costa L, Prete M, Navarini L, Atzeni F, Guggino G, Perosa F, Cantarini L, Frediani B, Montecucco C, Ciccia F, Giacomelli R, Cipriani P. Ruscitti P, et al. Among authors: balduzzi s. Clin Rheumatol. 2022 Nov;41(11):3597. doi: 10.1007/s10067-022-06357-y. Clin Rheumatol. 2022. PMID: 36040674 No abstract available.
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
De Stefano L, Balduzzi S, Bogliolo L, D'Onofrio B, di Lernia M, Mauric E, Milanesi A, Brandolino F, Rocca C, Chiricolo S, Manzo A, Montecucco C, Bugatti S. De Stefano L, et al. Among authors: balduzzi s. Clin Exp Rheumatol. 2023 Mar;41(3):667-675. doi: 10.55563/clinexprheumatol/0ltj1i. Epub 2022 Sep 21. Clin Exp Rheumatol. 2023. PMID: 36135948 Free article.
77 results